Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:Sanjiv_Patel
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focus |
precision medicine
drug discovery |
| gptkbp:foundedYear |
2016
|
| gptkbp:founder |
gptkb:Matthew_Jacobson
gptkb:David_E._Shaw gptkb:Mark_Murcko gptkb:Vicki_Sato |
| gptkbp:headquartersLocation |
gptkb:Cambridge,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Relay Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:IPODate |
2020
|
| gptkbp:notableProduct |
gptkb:RLY-1971
gptkb:RLY-2608 gptkb:RLY-4008 |
| gptkbp:numberOfEmployees |
approximately 300 (2023)
|
| gptkbp:publiclyTraded |
true
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:RLAY
|
| gptkbp:technology |
computational biology
protein motion analysis |
| gptkbp:website |
https://www.relaytx.com/
|
| gptkbp:bfsParent |
gptkb:SoftBank
|
| gptkbp:bfsLayer |
5
|